Pfizer bladder drug Toviaz gains US FDA clearance
This article was originally published in Scrip
Executive Summary
Pfizerplans a US launch of its overactive bladder drug Toviaz (fesoterodine fumarate) in the first half of 2009 now that the USFDAhas approved the anti-muscarinic agent for reducing symptoms of urinary frequency, urgency and incontinence.